1. Home
  2. MSTR vs NTRA Comparison

MSTR vs NTRA Comparison

Compare MSTR & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MicroStrategy Incorporated

MSTR

MicroStrategy Incorporated

N/A

Current Price

$86.12

Market Cap

48.4B

Sector

Technology

ML Signal

N/A

Logo Natera Inc.

NTRA

Natera Inc.

N/A

Current Price

$289.89

Market Cap

56.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MSTR
NTRA
Founded
1989
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.4B
56.7B
IPO Year
1998
2015

Fundamental Metrics

Financial Performance
Metric
MSTR
NTRA
Price
$86.12
$289.89
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
16
23
Target Price
$233.27
★ $412.36
AVG Volume (30 Days)
★ 13.2M
1.9M
Earning Date
10-29-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 0.65
EPS
N/A
★ N/A
Revenue
★ $463,456,000.00
$210,939,000.00
Revenue This Year
$4.81
$30.72
Revenue Next Year
$3.06
$21.67
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$81.81
$181.00
52 Week High
$198.40
$437.41

Technical Indicators

Market Signals
Indicator
MSTR
NTRA
Relative Strength Index (RSI) 21.95 27.42
Support Level N/A $189.54
Resistance Level $104.96 $334.60
Average True Range (ATR) 7.39 20.82
MACD -4.40 -8.12
Stochastic Oscillator 1.48 8.36

Price Performance

Historical Comparison
MSTR
NTRA

About MSTR MicroStrategy Incorporated

Strategy Inc is a bitcoin treasury company and a provider of business intelligence services. It is designed to provide investors varying degrees of economic exposure to Bitcoin by offering a range of securities, including equity and fixed-income instruments. The company also provides industry AI-powered enterprise analytics software. It has one reportable operating segment: the Software Business, which is engaged in the design, development, marketing, and sales of the company's enterprise analytics software platform through cloud subscriptions and licensing arrangements and related services (i.e., product support, consulting, and education). Geographically, the company operates in EMEA, U.S. and Other Regions, of which maximum revenue is derived from U.S..

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: